Tag
- Pfizer's paxlovid reduces the risk of COVID-19 by 26% 2022-11-07
- The battle between Pfizer and Gilead over COVID-19 drugs wil... 2022-11-03
- 1200 cases were newly prescribed by Junshi Biologic for mild... 2022-10-24
- Twenty-five COVID-19 Vaccines In China Enter Stages Of Clini... 2022-06-09
- Pfizer to Increase Production Capacity of COVID-19 Oral Drug... 2022-06-08
- Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant S... 2022-05-17
- As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid ... 2022-05-16
- Survey On Corona Deaths By Country 2022-05-09
- COVID-19 Drug Remdesivir Approved for Infants And Young Chil... 2022-04-28
- Roche's Q1 Performance Increases by 10%, And Total Revenue f... 2022-04-26
Market Analysis
- Palm Oil Market in December Experiences Volatile Decline Dec-30,2025
- December Cyclohexane Market Operates Weakly, Lacking Momentum for Price Increases Dec-30,2025
- Business Society: Both Supply and Demand Weak, Costs Hard to Sustain—Bisphenol A Set for Volatile Decline in 2025 Dec-30,2025
- December’s Coking Coal Market Primarily Exhibits Weak Performance Dec-30,2025
- This week, the soda ash market in China has been operating weakly Dec-30,2025